Thursday, May 23, 2013

• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu 9:31AM EDT)
• NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for CancerPR Newswire (Thu 8:15AM EDT)
• NWBO: Great Progress Made to Advance DCVax-L and DCVax-DirectZacks Small Cap Research (Thu 7:00AM EDT)

Tuesday, May 21, 2013

• NORTHWEST BIOTHERAPEUTICS INC FinancialsEDGAR Online Financials (Tue, May 21)

Thursday, May 16, 2013

• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, May 16)
• NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To OpenPR Newswire (Thu, May 16)

Wednesday, May 15, 2013

• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, May 15)

Tuesday, May 7, 2013

• Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trialsat Seeking Alpha (Tue, May 7)

Friday, May 3, 2013

• Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available OnlinePR Newswire (Fri, May 3)
• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Fri, May 3)

Wednesday, May 1, 2013

• With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curseat Seeking Alpha (Wed, May 1)

Tuesday, April 30, 2013

• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-K/A, Annual ReportEDGAR Online (Tue, Apr 30)

Tuesday, April 23, 2013

• RedChip Emerging Growth Showcase Takes Place May 1GlobeNewswire (Tue, Apr 23)

Monday, April 22, 2013

• NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements anEDGAR Online (Mon, Apr 22)

Thursday, April 18, 2013

• Northwest Biotherapeutics sells $10M in stockAP (Thu, Apr 18)
• NW Bio Announces $10 Million Registered Direct OfferingPR Newswire (Thu, Apr 18)
• NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free SurvivalPR Newswire (Thu, Apr 18)

Tuesday, April 16, 2013

• 4 Healthcare Stock Stories For Tuesday Investment Wellnessat Wall St. Cheat Sheet (Tue, Apr 16)
• NW Bio's Phase III Trial With DCVax®-L For Brain Cancer "Adopted" As A National Priority Trial In UKPR Newswire (Tue, Apr 16)

Thursday, April 11, 2013

• Northwest Biotherapeutics, Statistically Speakingat Seeking Alpha (Thu, Apr 11)

Add NWBO News to My Yahoo!